Filing Flows › Sensus Healthcare (SRTS) › Q2 2026
Sensus Healthcare (SRTS) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
Sensus Healthcare (SRTS) reported revenue of $2.3M for the second quarter 2026 (Q2 2026), -69% from a year earlier and -33% from the quarter before. Operating margin was -138.9%, net loss $8.7M (382.1% of revenue).
Sensus Healthcare, Q2 2026: revenue $2.3M (-69% year over year), operating margin -138.9%, net loss $8.7M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.3M | -33% | -69% |
| Operating profit | −$3.2M | — | — |
| Net earnings | −$8.7M | — | — |
| Operating cash flow | −$3.1M | — | -201% |
What changed
Revenue was $2.3M in Q2 2026, down 69% year over year and down 33% from the previous quarter. Product was the largest line at 54% of revenue. Product lost $4.1M year over year (down 77%), 83% of the total change.
Gross margin was 33.6%, down 6.1 points from Q2 2025. Operating costs exceeded revenue by $3.2M, an operating margin of -138.9%. Operating expenses fell 19% while revenue fell 69%. The quarter ended with a net loss of $8.7M, wider than the previous quarter's $2.6M loss.
Operating cash flow was −$3.1M. Non-cash charges added back $86K of depreciation and $70K of share-based compensation. Working capital and other items added $5.5M. Capital expenditures of $8K exceeded it, leaving free cash flow of −$3.1M.
Questions
What was Sensus Healthcare's revenue in the second quarter 2026?
Sensus Healthcare (SRTS) reported revenue of $2.3M for the second quarter 2026 (Q2 2026), -69% from a year earlier and -33% from the quarter before.
Was Sensus Healthcare profitable in the second quarter 2026?
Operating loss was $3.2M (-138.9% of revenue) and net loss $8.7M.
Source: Sensus Healthcare 10-Q on SEC EDGAR.